EV/FCFF - WuXi Biologics (Cayman) Inc (HKEX:2269) - Alpha Spread

WuXi Biologics (Cayman) Inc
HKEX:2269

Watchlist Manager
WuXi Biologics (Cayman) Inc Logo
WuXi Biologics (Cayman) Inc
HKEX:2269
Watchlist
Price: 11.06 HKD -0.18% Market Closed
Market Cap: 45.9B HKD
Have any thoughts about
WuXi Biologics (Cayman) Inc?
Write Note

EV/FCFF
Enterprise Value to FCFF

79.9
Current
-72.7
Median
27.6
Industry
Higher than median
Higher than industry value

Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

EV/FCFF
79.9
=
Enterprise Value
39.3B HKD
/
FCFF
447.2m CNY
All Countries
Close

EV/FCFF Forward Multiples

Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/FCFF
N/A
2-Years Forward
EV/FCFF
N/A
3-Years Forward
EV/FCFF
N/A

See Also

Discover More